Ipca Laboratories Ltd reports Q2 FY27 standalone revenue of ₹2,255.61 crore, up 17% YoY
- Consolidated revenue was ₹2,909.94 crore, up 14% YoY; net profit rose 33% to ₹375.13 crore.
- Standalone net profit increased 27% YoY to ₹387.29 crore; EBITDA margin was 26.61%, versus 25.46% a year ago.
- Consolidated results included a ₹24.26 crore exceptional provision for claims; auditors issued unmodified limited-review reports.
